Medicines for Malaria Venture (MMV) and Novartis announce positive data from their phase II/III CALINA study, demonstrating that a novel formulation of Coartem® developed for babies weighing less than 5kg with malaria has the required pharmacokinetic profile and therefore efficacy and safety.
Patrick Robert: Non, la France n a pas de responsabilité dans le génocide rwandais france-rwanda.info - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from france-rwanda.info Daily Mail and Mail on Sunday newspapers.